Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $72.9200 (4.31%) ($68.4400 - $74.2200) on Thu. Mar. 26, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.7% (three month average) | RSI | 36 | Latest Price | $72.9200(4.31%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -2.2% a day on average for past five trading days. | Weekly Trend | LGND declines -12.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(54%) XBI(52%) IWC(51%) IWM(50%) | Factors Impacting LGND price | LGND will decline at least -2.85% in a week (0% probabilities). VIXM(-27%) VXX(-17%) UUP(-11%) TLT(-9%) TIP(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.85% (StdDev 5.7%) | Hourly BBV | 0 () | Intraday Trend | 3.9% | | | |
|
1 - 5 Day Possible Target | $46.08(-36.81%) | Resistance Level | $85.64 | 5 Day Moving Average | $72.08(1.17%) | 10 Day Moving Average | $73.98(-1.43%) | 20 Day Moving Average | $85.64(-14.85%) | To recent high | -32.4% | To recent low | 15.1% | Market Cap | $1.172b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |